Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
EPO for Infarct Size Reduction in STEMI
NCT00149058Phase 2Unknown
- Sponsor
- Hammersmith Hospitals NHS Trust
- Start
- Oct 2005
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 2 trial of erythropoietin in myocardial infarction (MI), sponsored by Hammersmith Hospitals NHS Trust. Status: unknown.
02
Drugs
erythropoietin
03
Conditions
myocardial infarction (MI)
Beyond the preview
Go deeper on NCT00149058.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00149058.